These results provide us confidence to initiate MARITIME, a Phase III program across obesity and a number of related conditions, providing a unique potential new treatment option for patients. MariTide was well-tolerated across all dosage groups, with the most common side effects being mild gastrointestinal symptoms, such as nausea and diarrhea, which were largely mild, transient and primarily associated with the first dose, according to Amgen
Confirm specific active ingredients during your clinical consultation
Joining the dots: new approach to classifying adverse drug reactions
Theres no specific contraindication, but your kidney function needs to be monitored more closely
At TrimRx, we are committed to supporting your unique weight loss journey by providing personalized, medically supervised care combined with innovative solutions